Early Genitourinary Infections In Men May Raise Risk Of Urinary Tract Symptoms
Monday, 14 November 2005
NEW YORK (Reuters Health) - Men who describe a history of gonorrhea or young-onset prostatitis appear to be at increased risk for lower urinary tract symptoms (LUTS) later in life, according to a report in the American Journal of Epidemiology for November 1.
read more
|
The Combination Of Myofascial Trigger Point Release And Paradoxical Relaxation Training Shows Promise In The Treatment Of Chronic Pelvic Pain In Men
Friday, 15 July 2005
BERKELEY, CA (UroToday Inc.) - Chronic nonbacterial prostatitis/chronic pelvic pain syndrome (CPPS) in men continues to perplex and challenge the urologist in practice.
read more
|
Antibiotic Therapy Lowers Elevated PSA Level Seen With Prostatitis
Tuesday, 05 July 2005
NEW YORK (Reuters Health) - PSA elevations are relatively common with chronic bacterial prostatitis, new research indicates, but treatment with levofloxacin or ciprofloxacin can bring these levels back down.
read more
|
Individual Transrectal Needle Biopsies of the Prostate Are Able to Evaluate Degree of Prostatic Inflammation
Friday, 01 April 2005
BERKELEY, CA (UroToday Inc.) - The diagnosis of chronic prostatitis implies inflammation of the prostatic tissue.
read more
|
BJUI Mini Reviews - An Evidence-Based Approach to Understanding the Pharmacological Class Effect in the Management of Prostatic Diseases
Friday, 01 April 2005
This article focuses on efficacy, but
tolerability can also be an important factor
when choosing between drugs of the same
class, and will be discussed where relevant.
Login to read more...
|
Anti-Nanobacterial Treatment Relieves Pain of Chronic Prostatitis
Thursday, 27 January 2005
NEW YORK (Reuters Health) - Therapy designed to eliminate nanobacteria may alleviate the symptoms of chronic prostatitis/chronic pelvic pain syndrome (CPPS) in men who are refractory to other treatments, investigators report in the February issue of the Journal of Urology.
read more
|
Therapy Aimed at Treating Nanobacteria Proven Effective in Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Wednesday, 26 January 2005
BERKELEY, CA (UroToday Inc.) - Category III chronic prostatitis/chronic pelvic pain syndrome (CPPS) is a common debilitating condition of unclear etiology. Patients often have prostatic calcifications seen on transrectal ultrasound (TRUS) but their link to symptoms is controversial.
read more
|
Chronic Prostatitis Symptoms May Be Due to Bladder Pathology
Wednesday, 12 January 2005
BERKELEY, CA (UroToday Inc.) - Patients with chronic prostatitis and interstitial cystitis can be the some of the most difficult patients to diagnose and treat. There is some speculation that the two diseases may be closely connected.
read more
|
Ratio of Free-to-Total PSA Found to be Significantly Different in Prostate Cancer and NIH Category IV Prostatitis
Monday, 13 December 2004
BERKELEY, CA (UroToday Inc.) - Prostate cancer, benign prostatic hyperplasia and prostatitis are well established causes of elevated prostate specific antigen (PSA).
read more
|
Neither Ciprofloxacin nor Tamsulosin Proven Effective for the Treatment of Men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Thursday, 02 December 2004
BERKELEY, CA (UroToday Inc.) - Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common disorder and accounts for approximately 2 million visits to physicians annually in the United States.
read more
|
Azithromycin and Ofloxacin Found to be Most Active against Chlamydia in Men with Chronic Lower Urinary Tract Symptoms
Tuesday, 30 November 2004
BERKELEY, CA (UroToday Inc.) - Chlamydia trachomatis is the most common sexually transmitted disease agent worldwide and is known to be one of the etiological microorganisms of chronic prostatitis.
read more
|
Ciprofloxacin, Tamsulosin Ineffective for Chronic Prostatitis
Tuesday, 19 October 2004
NEW YORK (Reuters Health) - Neither the quinolone antibiotic ciprofloxacin nor the alpha-adrenergic receptor antagonist tamsulosin relieves symptoms of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) after 6 weeks of treatment, results of a multicenter study suggest.
read more
|
Study: Boehringer Ingelheim's, Abbott's Flomax Effective for Prostatitis
Friday, 12 March 2004
A study comparing Boehringer Ingelheim's Flomax (tamsulosin hydrochloride) with a placebo found that the drug was better at alleviating the symptoms of chronic prostatitis/chronic pelvic pain syndrome, a news source reports.
read more
|
Finasteride, but not Saw Palmetto, Useful in Treating NIH Category III Prostatitis/Chronic Pelvic Pain Syndrome
Tuesday, 17 February 2004
BERKELEY, CA (UroToday Inc.) - Drs. S. Kaplan, M. A. Volpe and A. E. Te used a single blind, randomized parallel study to treat 64 patients who had category III chronic prostatitis/chronic pelvic pain syndrome with either saw palmetto or finasteride for one year.
read more
|
Patients with Prostatitis NIH IIIB (Prostatodynia) Show Significant Abnormalities of Ejaculate
Wednesday, 10 December 2003
In their introduction to this article, Drs. Engeler, Hauri and John of St. Gallen, Switzerland point out that prostatitis and male infertility each account for about 8% of all urologic office visits. However, the relationships between the two ?remain obscure?.
read more
|
LEVAQUIN® Receives FDA Approval for Treatment of Chronic Bacterial Prostatitis
Thursday, 29 May 2003
Raritan, NJ (May 29, 2003) - The U.S. Food and Drug Administration (FDA) has approved LEVAQUIN® (levofloxacin) Tablets/Injection and LEVAQUIN® (levofloxacin in five percent dextrose) Injection for the treatment of chronic bacterial prostatitis due to Escherichia coli, Enterococcus faecalis or Staphylococcus epidermidis. Chronic bacterial prostatitis is a recurrent or persistent infection of the prostate gland and the number one reason men under the age of 50 visit urologists. With this indication, LEVAQUIN® becomes the only once-daily fluoroquinolone indicated to treat chronic bacterial prostatitis.
read more
|
Prostatitis 
